Medtronic Expands 2 High-Risk Class I Recalls Of MiniMed Infusion Pumps, Remote Controllers
Medtronic on 5 October widened its 2019 recall of MiniMed pump models 630G and 670G because there’s a chance they can over- or under-dose patients. It also expanded an unrelated 2018 recall of remote controllers used with specific MiniMed pumps due to cybersecurity concerns.
You may also be interested in...
Medtronic’s MiniMed series insulin pumps could allow unauthorized hackers to change the amount of insulin delivered to a patient, the FDA says.
The lawsuit says that Medtronic continued to predict that the new insulin pump would be FDA-approved shortly, even as other regulatory issues and recalls in the diabetes division made that less likely.
The missive reflects quality systems issues at the Northridge, CA headquarters of Medtronic’s diabetes division. Analysts are split on what the warning letter’s long-term impact may be.